Global Cord Blood
CORBF
$1.25
Share price
0.00%
Change (1 day)
-58.19%
Change (1 year)
Categories
Earnings for Global Cord Blood (CORBF)
Earnings in 2022 (TTM): $94.91 M
According to Global Cord Blood's latest financial reports the company's current earnings (TTM) are $94.91 M. In 2021 the company made an earning of $95.08 M an increase over its 2020 earnings that were of $82.1 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Global Cord Blood from 2008 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $94.91 M | -0.17% |
| 2021 | $95.08 M | 15.8% |
| 2020 | $82.1 M | 9.77% |
| 2019 | $74.79 M | 46.97% |
| 2018 | $50.89 M | 5.37% |
| 2017 | $48.29 M | 22.64% |
| 2016 | $39.38 M | -3.71% |
| 2015 | $40.89 M | -6.8% |
| 2014 | $43.88 M | 8.69% |
| 2013 | $40.37 M | 19.86% |
| 2012 | $33.68 M | 39.47% |
| 2011 | $24.15 M | 34.07% |
| 2010 | $18.01 M | 124.94% |
| 2009 | $8 M | -562.99% |
| 2008 | -$1.73 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 RadNet RDNT | $0.10 B | 8.82% | 🇺🇸 USA |
 National Healthcare
NHC | $89.06 M | -6.17% | 🇺🇸 USA |
 NeoGenomics
NEO | -$90.19 M | -195.02% | 🇺🇸 USA |
 Cryo-Cell CCEL | -$12.13 M | -112.78% | 🇺🇸 USA |